ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,050.61
-0.39%
US Tech 100
21,405.20
-0.56%
Dow Jones
43,449.90
-0.61%
Brent Oil
73.065
-0.05%
Bitcoin
103,659.71
-2.35%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Oxford Biomedica Plc (OXB) Quote

Oxford Biomedica Plc

Oxford Biomedica Plc (OXB)

LSE
421.00
-2.50
(-0.59%)
Closed December 18 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
421.00
Bid
421.50
Ask
424.00
Volume
79,441
420.00 Day's Range 426.00
167.00 52 Week Range 450.00
Market Cap
443.565M
Previous Close
423.50
Open
421.00
Last Trade
14796
@
423.60293
(O)
Last Trade Time
Financial Volume
335,580p
VWAP
422.4265
Average Volume (3m)
189,795
Shares Outstanding
105,359,856
Dividend Yield
-
PE Ratio
-2.41
Earnings Per Share (EPS)
-1.75
Revenue
89.54M
Net Profit
-184.16M

About Oxford Biomedica Plc

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
www.oxb.com
Headquarters
Oxford, Gbr
Founded
-
Oxford Biomedica Plc is listed in the Medicinal Chems,botanicl Pds sector of the London Stock Exchange with ticker OXB. The last closing price for Oxford Biomedica was 423.50p. Over the last year, Oxford Biomedica shares have traded in a share price range of 167.00p to 450.00p.

Oxford Biomedica currently has 105,359,856 shares outstanding. The market capitalization of Oxford Biomedica is £446.20 million. Oxford Biomedica has a price to earnings ratio (PE ratio) of -2.41.

Ask ADVFN Intelligence (AI)

OXB Latest News

More News

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC 02 December 2024     OXB Total Voting Rights   Oxford, UK - 02 December 2024: Oxford Biomedica Plc ( "OXB" or the "Company"; LSE: OXB), a quality and innovation-led cell...

December 02 2024
RNS Regulatory News

Oxford Biomedica PLC Grant of options

Oxford Biomedica PLC 22 November 2024     Grant of options   Oxford, UK - 22 November 2024: Oxford Biomedica plc ("OXB" or the "Company"; LSE: OXB), a quality and innovation-led cell and gene...

November 22 2024
RNS Regulatory News

OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical development

OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical development Oxford, UK – 20 November 2024: OXB (LSE: OXB), a quality and...

November 20 2024
GlobeNewswire Inc.

Oxford Biomedica PLC Board Changes

Oxford Biomedica PLC 18 November 2024     Board Changes -     Appointment of Colin Bond, a highly experienced Board member and Audit Committee Chair with extensive international CDMO and...

November 18 2024
RNS Regulatory News

Oxford Biomedica PLC OXB to present at Jefferies Healthcare Conference

Oxford Biomedica PLC 15 November 2024         OXB to present at the Jefferies London Healthcare Conference Oxford, UK - 15 November 2024: OXB (LSE: OXB), a quality and innovation-led cell and...

November 15 2024
RNS Non-Regulatory

Oxford Biomedica PLC Grant of options

Oxford Biomedica PLC 05 November 2024     Grant of options   Oxford, UK - 05 November 2024: Oxford Biomedica plc ("OXB" or the "Company"; LSE: OXB), a quality and innovation-led cell and gene...

November 05 2024
RNS Regulatory News

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC 04 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name OXFORD BIOMEDICA PLC UK or Non-UK Issuer UK 2...

November 04 2024
RNS Regulatory News

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC 01 November 2024       OXB Total Voting Rights   Oxford, UK - 01 November 2024: Oxford Biomedica Plc ( "OXB" or the "Company"; LSE: OXB), a quality and innovation-led cell...

November 01 2024
RNS Regulatory News

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC 31 October 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name OXFORD BIOMEDICA PLC UK or Non-UK Issuer UK 2...

October 31 2024
RNS Regulatory News

Oxford Biomedica PLC Block Listing Application

Oxford Biomedica PLC 21 October 2024     OXB Block Listing Application Oxford, UK - 21 October 2024: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces...

October 21 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4-0.941176470588425433411.5135425426.83419777DE
414.53.56703567036406.5438400.5150478423.59009265DE
126116.9444444444360450360189795404.5331915DE
2612140.3333333333300450296159652376.45188547DE
52223112.626262626198450167212073285.45820895DE
156-649-60.654205607510701294164.4189017380.12226148DE
260-209-33.17460317466301678164.4179021600.56082059DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TM1Technology Minerals Plc
0.265p
(140.91%)
635.73M
HUMHummingbird Resources Plc
2.30p
(39.39%)
8.51M
QEDQuadrise Plc
6.00p
(29.03%)
28.48M
LPALpa Group Plc
72.00p
(26.32%)
63.26k
DARDar Global Plc
$ 6.00
(22.45%)
16.75k
APIAbrdn Property Income Trust Limited
9.51p
(-84.36%)
13.57M
KDNCCadence Minerals Plc
1.65p
(-40.00%)
17.87M
BLUBlue Star Capital Plc
0.015p
(-25.00%)
18.2M
SYMESupply@me Capital Plc
0.0034p
(-22.73%)
1.43B
SCGLSealand Capital Galaxy Limited
1.40p
(-22.22%)
6.15M
NTVONativo Resources Plc
0.0021p
(-12.50%)
4.78B
SYMESupply@me Capital Plc
0.0034p
(-22.73%)
1.43B
TRPTower Resources Plc
0.031p
(8.77%)
637.54M
TM1Technology Minerals Plc
0.265p
(140.91%)
635.73M
ORCPOracle Power Plc
0.026p
(-3.70%)
340.06M

Discussion

View Full Feed
zerosnoop zerosnoop 5 minutes ago
This RECENT news is MASSIVE. CONFIRMED the PROVEN AOT is being sold GLOBALLY. The PROVEN AOT is a "GAME CHANGER" for the oil industry.

https://www.accesswire.com/952292/qs-energy-achieves-phase-4-milestone-with-southeast-asias-leading-energy-producer

https://ir.qsenergy
QSEP
stockstobuy stockstobuy 6 minutes ago
I cant believe this scam is still running after all these years. Any tweets from NSAV meant nothing and will result to more people losing money just like what they did in 2020,spewling lies and lies to pump the stock. NOw they are going to sue Mr Grover who is telling the truth like they have the mo
NSAV
norisknorewards norisknorewards 6 minutes ago
I only.. .


You only see a negative slant, why?
NWBO
NoMoDo NoMoDo 6 minutes ago
Was it though? I know of one person that made a ton of money there and still held some shares. Then he added a ton. Like a ton. Because the concept had real promise. Sure, the CEO was new, but he eventually figured things out. Then somehow he brought a group of businesses together to create so
HMBL
igotthemojo igotthemojo 7 minutes ago
"Sad you can't own what you said"

i AM owning what i said...but i am owning EVERYTHING i said...caveats and all...

"Like I said, show it or you own it"

i showed it in my reply to webstinker...but you want to pretend you didnt see it...

"I w
KBLB
ysung ysung 8 minutes ago
Wow more good news !!

SEC will be totally run by republicans next year !!

Caroline Crenshaw is canned as the banking committee cancelled the vote for tmrw !!!

Ripple appeal lawsuit by SEC will likely be 
dropped !!
XRPUSD
agua77 agua77 8 minutes ago
You might as well merge the two tickers and focus energies instead of trying to build out several simultaneously.

There’s an idea.
ZHUD
4u2nv2 4u2nv2 9 minutes ago
Did VISTAinnova Strategy buy the 4.5 million in MCIC this week? It's a thought.
MCIC
The Whale The Whale 10 minutes ago
Should get the news today.

$ICTY
ICTY
MasterBlastr MasterBlastr 10 minutes ago
Fortunately we have fickle minute-mental voters to make 2026 look better already. Just a matter of stalling and litigating, and hope we can live until we can run another election to correct this last one.
Huggy Bear Huggy Bear 11 minutes ago
I remember perfectly well, and it was all SCAMMING.

And this latest circus show is more of the same, scamming.
HMBL
NoMoDo NoMoDo 13 minutes ago
No...goofy... it really happened. You might not remember, but it really happened.
HMBL
jjjjjjjj jjjjjjjj 13 minutes ago
I have 42M shares in my individual account and 7M shares in the rest I acquired at $0.15 with kids. I lost a lot of money. Don't invest if you couldn't lost it all. It is a chance of lifetime. No more shares to borrow! Market makers and short sellers combine shares are fewer than share holders set
MJNA
hondaboost hondaboost 14 minutes ago
NUKK 0.2935 0.3008 0.2601 0.2734 -0.0306 1,228,680 69,714 0.2765 0.3055
2024-10-22 Q NUKK 0.2602 0.3699 0.251 0.304 0.0414 2,896,335 33,108 0.2576 0.304
2024-10-21 Q NUKK 0.2662 0.27 0.2351 0.2626 -0.0036 1,446,129 65,182 0.2377 0.266
2024-10-18 Q NUKK 0.2589 0.2776 0.2401 0.266
NUKK
agua77 agua77 14 minutes ago
I see nothing within the press release which states the intellectual property/patent…I also made that statement in one of my previous posts. I actually think the term “patent” was used by a poster and it stuck in our minds. It sounds more like a R&D company that wants to build out systems. This does
ZHUD
Huggy Bear Huggy Bear 14 minutes ago
Ahh scamming.... Good, right?
HMBL
mr_sano mr_sano 14 minutes ago
Only a moron would applaud getting split in half.
QSEP
excel excel 14 minutes ago
Yep, exactly.
Practice reps.
Mental prep.

I wonder if Cousins got hurt he kept it to himself either for money? ego?
I don't know but he is way off.
dstock07734 dstock07734 15 minutes ago
You know why I put you on ignore list. Your stupidity is profound. You got lucky this time since I saw your post and replied.

Do you know when Merck started the construction? It was in October 2020. By that time, did Merck have any verifiable data about the efficacy on whatever you ta
NWBO
govprs govprs 18 minutes ago
See page 21 https://www.otcmarkets.com/otcapi/company/financial-report/417444/content
GDVM
agua77 agua77 18 minutes ago
Of course we don’t know that…we only hear promises about “numbers”. That’s how these hopium otc tickers work and on top of it you have a CEO trying to insight emotion as opposed to showing the math.

What’s the worse approach to trading and investing? Emotion
ZHUD
zerosnoop zerosnoop 19 minutes ago
The below is so TRUE in regards to QSEP

A stock basher is someone who manipulates the market to cause a drop in asset prices.

Stock bashers disseminate misinformation in the hopes that investors will believe the false claims and sell their stock before the price drops.
QSEP
Horseb4CarT Horseb4CarT 19 minutes ago
You've probably heard this many times too, but this time is different!
NWBO
zerosnoop zerosnoop 19 minutes ago
I notice the paid bashers, tax cheats, fraudsters, grubs, uneducated fools with a low IQ & compulsive liars are getting more desperate with their nonsense. The short squeeze is fast approaching. The PROVEN AOT is going GLOBAL.

NAKED SHORT SELLING gets reported differently & isn't part
QSEP
zerosnoop zerosnoop 19 minutes ago
And who are the uneducated fools with a low IQ who incorrectly predicted a 500 million share cap increase ? The same fools who don't understand what "debt financing" is, hah hah. It has nothing to do with dilution.

We are seeking to finalize debt financing to ensure a smooth operation
QSEP

Your Recent History

LSE
OXB
Oxford Biomedica
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved